Asthma | Diseases of the Lung, Phase IIA

Tezepelumab COPD Exacerbation Study (COURSE)

Volunteers
Health Professionals

What is the purpose of this trial?

To evaluate the effect of tezepelumab as compared with placebo on COPD exacerbations in subjects with moderate to very severe COPD

Trial with
AstraZeneca Pharmaceutical LP
Ages
40 years - 80 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Jean Estrom

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Geoffrey Chupp, MD
Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine ); Director, Yale Center for Asthma and Airways Disease (YCAAD), Pulmonary, Critical Care & Sleep Medicine; Director, Pulmonary Function Laboratory, Yale-New Haven Hospital, Pulmonary, Critical Care & Sleep Medicine

Sub-Investigators

Last Updated
07/18/2023
Study HIC
#2000026323